Captrust Financial Advisors Celcuity Inc. Transaction History
Captrust Financial Advisors
- $30 Billion
- Q1 2024
A detailed history of Captrust Financial Advisors transactions in Celcuity Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 467,245 shares of CELC stock, worth $7.38 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
467,245
Previous 544,835
14.24%
Holding current value
$7.38 Million
Previous $7.94 Million
27.14%
% of portfolio
0.03%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding CELC
# of Institutions
82Shares Held
22.9MCall Options Held
24.9KPut Options Held
4K-
Perceptive Advisors LLC New York, NY2.36MShares$37.3 Million1.07% of portfolio
-
Morgan Stanley New York, NY2.35MShares$37.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.73MShares$27.4 Million3.06% of portfolio
-
Commodore Capital LP New York, NY1.56MShares$24.6 Million2.9% of portfolio
-
Baker Bros. Advisors LP New York, NY1.55MShares$24.5 Million0.42% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $236M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...